Medical Devices
-
FDA warns on unauthorized blood pressure, infant monitoring devices
Many of these devices currently sold over-the-counter do not have marketing authorization, the agency said in a notice.
By Elise Reuter • Sept. 17, 2025 -
Stryker, Siemens Healthineers partner on neurovascular robot
The companies will develop a robotic system to improve patient outcomes in complex hemorrhagic cases and time-sensitive ischemic strokes.
By Susan Kelly • Sept. 17, 2025 -
Explore the Trendline➔
Permission granted by Boston ScientificTrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
BD expands Class I recall to cover 15 more Alaris pump infusion sets
BD, which has not received any complaints related to the issue, previously discontinued the devices affected by the expanded recall.
By Nick Paul Taylor • Sept. 17, 2025 -
Retrieved from Insulet on September 16, 2025
Insulet names new CFO; Dexcom CEO on leave
Flavia Pease will take over as Insulet’s CFO on Sept. 30. Elsewhere, outgoing Dexcom CEO Kevin Sayer is taking a medical leave of absence.
By Elise Reuter • Sept. 16, 2025 -
Deep Dive
How three companies are using foundation models in radiology
Some firms, such as Aidoc, are working directly with the FDA. Others, such as HOPPR, are offering their foundation models for medtech companies to build their own AI tools.
By Elise Reuter • Sept. 16, 2025 -
Deep Dive
Foundation models are medtech’s newest trend. But what are they?
The AI models, which are built on massive datasets and can be adapted to multiple tasks, have become a part of medtech companies’ lexicon in the past few years.
By Elise Reuter • Sept. 15, 2025 -
Intuitive da Vinci 5 updates offer feedback during surgery
Three new software features for Intuitive’s most advanced soft tissue surgical robot have received 510(k) clearance from the Food and Drug Administration.
By Susan Kelly • Sept. 15, 2025 -
B. Braun buys True Digital Surgery for microscopy technology
The acquisition gives B. Braun control of a company that provides technology for its Aeos robotic digital microscope.
By Nick Paul Taylor • Sept. 15, 2025 -
AI drives medtech investment in 2025
Medical device companies working with artificial intelligence raised funding and were acquisition targets in recent months.
By Elise Reuter • Sept. 12, 2025 -
Masimo, Philips extend patient monitoring partnership
The multi-year agreement comes two months after Philips renewed a partnership for patient monitoring technologies with Masimo competitor Medtronic.
By Susan Kelly • Sept. 11, 2025 -
Patients call for more medical device user fee funding, FDA staffing
Commenters to the FDA also advocated for safety reforms and for industry funds to be used for post-market monitoring.
By Elise Reuter • Sept. 11, 2025 -
Philips under investigation by Paris Prosecutor’s Office over recalled respiratory devices
The prosecutor’s office opened an investigation in June, with charges including aggravated fraud and failure to report incidents that pose serious health risks.
By Elise Reuter • Sept. 10, 2025 -
Boston Scientific inks $88M Elutia deal to challenge Medtronic
BTIG analysts estimate that Elutia’s Elupro and Medtronic’s TYRX are competing for a $600 million opportunity in the U.S. cardiac rhythm management sector.
By Nick Paul Taylor • Updated Sept. 11, 2025 -
Pulse wins IDE approval; Galvanize pulls in $100M
Pulse Biosciences will study PFA in cardiac surgery. Meanwhile, Galvanize Therapeutics also named a new CEO, and PFA pioneer Steven Mickelsen has launched another company.
By Susan Kelly • Sept. 9, 2025 -
Microbot receives 510(k) clearance for endovascular robot
The company will now complete final commercial activities in preparation for targeting the 2.5 million peripheral vascular procedures performed in the U.S. each year.
By Nick Paul Taylor • Sept. 9, 2025 -
Ronovo Surgical raises $67M, led by J&J venture arm
Ronovo, a Chinese surgical robotics company, will also team with a J&J subsidiary in Shanghai to sell Ronovo’s soft tissue platform and complementary J&J technologies.
By Susan Kelly • Sept. 8, 2025 -
Senseonics inks deal to bring CGM commercialization back in-house
BTIG analysts said Senseonics is doubling down on its belief an inflection point in patient demand is imminent, but the company will need a large sales force to win market share.
By Nick Paul Taylor • Sept. 8, 2025 -
AI firm Ketryx raises $39M, adds former Medtronic CEO as investor
The company, which helps medtech companies with AI compliance, has raised more than $55 million to date.
By Elise Reuter • Sept. 5, 2025 -
Medtronic trial of Hugo robot in hernia repair hits primary endpoints
The company reported a 100% surgical success rate, beating the pre-specified 85% performance goal to meet the trial’s primary effectiveness endpoint.
By Nick Paul Taylor • Sept. 5, 2025 -
Dexcom to lay off about 350 people
The diabetes technology company said the cuts are part of broader changes to its structure, including eliminating operations roles in San Diego and shifting those positions to Arizona.
By Elise Reuter • Sept. 4, 2025 -
Renal denervation gets strong backing from cardiologists ahead of Medicare coverage decision
Doctors told the Centers for Medicare and Medicaid Services that more patients need access to the procedure, with one calling it the start of a new era in hypertension management.
By Susan Kelly • Sept. 4, 2025 -
Kardium receives FDA OK for pulsed field ablation system
The company raised $250 million in July to expand its manufacturing capabilities and establish multiple teams to support the launch.
By Nick Paul Taylor • Sept. 4, 2025 -
3 medtech takeaways from ESC 2025
Pulsed field ablation and transcatheter aortic valve implants were in focus at the European Society of Cardiology Congress in Madrid.
By Susan Kelly • Sept. 3, 2025 -
Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe
Analysts said the companies should benefit “as the therapy algorithm is further streamlined and additional patients are encouraged to receive TAVR.”
By Nick Paul Taylor • Sept. 3, 2025 -
Medtronic advances Abbott partnership with FDA nod
The company received FDA authorization to pair its 780G insulin pump with a glucose sensor made by Abbott, and to use the device for Type 2 diabetes.
By Elise Reuter • Sept. 2, 2025